DNA methylation-based classification of hematolymphoid neoplasms.

Saved in:
Bibliographic Details
Title: DNA methylation-based classification of hematolymphoid neoplasms.
Authors: Saksena A; National Cancer Institute, United States., Siewert C; German Cancer Research Center (DKFZ), Germany., Turakulov R; National Cancer Institute, BETHESDA, Maryland, United States., Singh O; National Cancer Institute, BETHESDA, Maryland, United States., Abdullaev Z; NIH, Bethesda, Maryland, United States., Zhou T; UTHSCSA, AUSTIN, United States., Karrs JX; Dartmouth Hitchcock, Lebanon, New Hampshire, United States., Castro JVA; A.C.Camargo Cancer Center, Sao Paulo, Brazil., Riley D; National Cancer Institute, Bethesda, Maryland, United States., Skarshaug S; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States., Zgonc V; National Cancer Institute, BETHESDA, Maryland, United States., Sultanaeva L; National Cancer Institute, BETHESDA, Maryland, United States., Teng R; National Cancer Institute, BETHESDA, Maryland, United States., Xi L; National Institutes of Health, Bethesda, Maryland, United States., Kreitman RJ; National Cancer Institute, NIH, Bethesda, Maryland, United States., von Deimling AV; University of Heidelberg, Heidelberg, Germany., Duran-Ferrer M; Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain., Martin-Subero JI; IDIBAPS, Barcelona, Spain., Campo E; Hospital Clinic of Barcelona, Spain., Englert B; University of Helsinki, Helsinki, Finland., Richter J; Christian-Albrechts University Kiel, Kiel, Germany., Klapper W; Department of Pathology, Kiel, Kiel, Germany., Anagnostopoulos I; University of Würzburg, Institute of Pathology, Würzburg, Germany., Rosenwald A; Universität Würzburg., Wobser M; University Hospital Wuerzburg, Wuerzburg, Germany., Fend F; University of Tubingen, Tuebingen, Germany., Quintanilla-Martinez L; University Hospital Tuebingen, Tuebingen, Germany., Ferrer G; Josep Carreras Leukaemia Research Institute (IJC), Barcelona, Spain., Esteller M; Institucio Catalana de Recerca i Estudis Avançats (ICREA), Centro de Investigacion Biomedica en Red Cancer (CIBERONC), Physiological Sciences Department, School of Medicine and Health Sciences, University of Barcelona (UB), Spain., Piris MA; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Hummel M; Charite - University Medicine Berlin; Campus Benjamin Franklin, Berlin, Germany., Pittaluga S; National Institutes of Health National Cancer Institute, Bethesda, Maryland, United States., Raffeld M; National Institutes of Health, Bethesda, Maryland, United States., Jaffe ES; National Cancer Institute, National Institutes of Health, Bethesda, Maryland, United States., Capper D; German Cancer Research Center (DKFZ), Germany., Aldape K; National Cancer Institute, BETHESDA, Maryland, United States.
Source: Blood advances [Blood Adv] 2026 Apr 23. Date of Electronic Publication: 2026 Apr 23.
Publication Type: Journal Article
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2473-9537
DOI:10.1182/bloodadvances.2024015275